Developing a Community-Based Facility to Support Next Generation Biomedical HIV Research
开发基于社区的设施以支持下一代艾滋病毒生物医学研究
基本信息
- 批准号:10547892
- 负责人:
- 金额:$ 200万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-16 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAwardClinical ResearchClinical Trials UnitCollaborationsCommunitiesCountryEpidemicFundingGoalsHIVHealthcareHomeInstitutionInvestigationMentorshipNeighborhoodsPharmacy facilityPoliciesPreventionProtocols documentationPublic HealthResearchResearch PersonnelScienceSterilitySumTranslational ResearchTranslationsUniversitiesWalkersWashingtonWorkbasebehavioral healthclinical centerco-infectioncommunity centercomorbidityefficacy researchhealth inequalitiesmarginalized communitynext generationprogramspublic health researchracial disparityresearch facilitysocial spacesocioeconomicssquare foottraining opportunityunderserved communityward
项目摘要
Project Summary/Abstract
Wards 7 and 8 in Washington, DC are home to some of the nation’s most stark racial inequities in health and
socioeconomic indicators, with residents of these wards being underserved in healthcare and
underrepresented public health research. Among these health inequities is a significantly higher burden of HIV,
yet none of the major HIV-related research facilities in DC are located within these wards. Two central hubs for
HIV research within DC—the DC Center for AIDS Research and the DC Clinical Trials Unit—both operate
primarily out of facilities in Ward 2, and the efficacy of this research would be enhanced by stronger
representation of marginalized communities in protocols to optimize the impact of this work on the
neighborhoods in DC that are the hardest hit by HIV, its co-morbidities/co-infections, and other co-occurring
health inequities. Thus, the goal of the proposed HIV research facilities award is to fund the build-out of a new
state-of-the-art, community-centered clinical and translational HIV research facility located within the new
flagship Whitman-Walker building currently being constructed in DC’s Ward 8, to be used jointly by HIV
investigators at both Whitman-Walker and George Washington University (GWU). The proposed facility would
add 10,300 square feet of dedicated research space, including a state-of-the-art research lab and a research
pharmacy with capacity for sterile compounding of investigational products, more than doubling the available
space for research in this building and serving as the primary collaborative hub for HIV-focused research in
Southeast DC. Doing so will significantly: (1) increase the overall volume of research able to be conducted; (2)
enhance the collaboration of Whitman-Walker and GWU investigators, bolstering the strategic integration of
both research programs; (3) expand the scope and technical capabilities of the work that is possible not only
for both institutions but also within these specific neighborhoods of DC; (4) indirectly expand the available
space for social/behavioral and public health research as well by relocating all clinical and translational
research to the new facility; (5) provide local communities with greater access to and representation in cutting-
edge HIV science and new opportunities to help inform these collaborative research agendas; (6) facilitate
greater translation and dissemination of breakthroughs in HIV science within local and national policy contexts
that will benefit both local DC communities and communities across the country; and (7) promote new
opportunities for training and mentorship. In sum, the proposed project will have a multiplicative impact on both
local and national HIV research through this unique plan to increase the size and scope of facilities available
and co-locate two of DC’s top HIV research institutions to leverage existing partnerships and forge new,
community-centered collaborative research agendas. In doing so, the award will bring cutting-edge
breakthroughs in HIV treatment and prevention science directly to underserved communities most impacted by
the HIV epidemic in DC and has significant potential for public health impact for decades to come.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H. Jonathon Rendina其他文献
H. Jonathon Rendina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H. Jonathon Rendina', 18)}}的其他基金
Multilevel strategies to understand and modify the role of structural and environmental context on HIV inequities for sexual and gender minorities of color
了解和改变结构和环境背景对有色人种和性别少数群体艾滋病毒不平等的作用的多层次战略
- 批准号:
10594549 - 财政年份:2022
- 资助金额:
$ 200万 - 项目类别:
Multilevel strategies to understand and modify the role of structural and environmental context on HIV inequities for sexual and gender minorities of color
了解和改变结构和环境背景对有色人种和性别少数群体艾滋病毒不平等的作用的多层次战略
- 批准号:
10462238 - 财政年份:2022
- 资助金额:
$ 200万 - 项目类别:
Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U
了解新诊断的 HIV 男性的病毒抑制,为 TasP 和 U=U 的实施提供信息
- 批准号:
10361553 - 财政年份:2020
- 资助金额:
$ 200万 - 项目类别:
Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U
了解新诊断的 HIV 男性的病毒抑制,为 TasP 和 U=U 的实施提供信息
- 批准号:
10390620 - 财政年份:2020
- 资助金额:
$ 200万 - 项目类别:
Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U
了解新诊断的 HIV 男性的病毒抑制,为 TasP 和 U=U 的实施提供信息
- 批准号:
10013526 - 财政年份:2020
- 资助金额:
$ 200万 - 项目类别:
Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men
检查全国范围内大量高危男性中 HIV 血清转化的可修改心理社会预测因素
- 批准号:
10415523 - 财政年份:2017
- 资助金额:
$ 200万 - 项目类别:
Testing a Biopsychosocial Model of Minority Stress and Health for HIV-Positive Men
测试艾滋病毒阳性男性的少数群体压力和健康的生物心理社会模型
- 批准号:
10394542 - 财政年份:2017
- 资助金额:
$ 200万 - 项目类别:
Testing a Biopsychosocial Model of Minority Stress and Health for HIV-Positive Men
测试艾滋病毒阳性男性的少数群体压力和健康的生物心理社会模型
- 批准号:
9977286 - 财政年份:2017
- 资助金额:
$ 200万 - 项目类别:
Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men
检查全国范围内大量高危男性中 HIV 血清转化的可修改心理社会预测因素
- 批准号:
9929734 - 财政年份:2017
- 资助金额:
$ 200万 - 项目类别:
Testing a Biopsychosocial Model of Minority Stress and Health for HIV-Positive Men
测试艾滋病毒阳性男性的少数群体压力和健康的生物心理社会模型
- 批准号:
9482549 - 财政年份:2017
- 资助金额:
$ 200万 - 项目类别:
相似海外基金
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 200万 - 项目类别:
IGF::OT::IGF PURPOSE: TO AWARD THE BASE PERIOD FOR CLINICAL RESEARCH COORDINATING CENTER FOR THE NIDA CTN POP: 08/14/2015-08/13/2016.
IGF::OT::IGF 目的:授予 NIDA CTN POP 临床研究协调中心基期:2015 年 8 月 14 日至 2016 年 8 月 13 日。
- 批准号:
9288087 - 财政年份:2015
- 资助金额:
$ 200万 - 项目类别:
K30: Clinical Research Curriculum Award - WMC
K30:临床研究课程奖 - WMC
- 批准号:
6846424 - 财政年份:2005
- 资助金额:
$ 200万 - 项目类别: